Peking University People's Hospital | Pioneering Medical Excellence Since 1918

Hematology Department (血液科): The Hematology Department at Peking University People's Hospital is a globally recognized and nationally leading center for hematological research and treatment. It is consistently ranked as one of the top departments in China, having topped the China Hospital Best Specialty Reputation for Hematology for 11 consecutive years and ranked first in both the 2022 China Hospital Technology Value (STEM) and five-year total Technology Value (ASTEM) for Hematology. Also known as the Peking University Institute of Hematology, it was formally established in 1981, with Academician Lu Daopei pioneering bone marrow transplantation in China, performing the first successful allogeneic bone marrow transplant in China in August 1981. Under the leadership of Academician Huang Xiaojun since 2004, the department developed the "Beijing Protocol" for non-T-cell-depleted haploidentical (half-matched) bone marrow transplantation. This innovative approach has made HSCT accessible to nearly "everyone with a donor," transforming previous international consensus and becoming an internationally recognized standard, accounting for approximately one-quarter of all such transplants in China, with long-term disease-free survival rates for acute and chronic leukemia averaging over 70%. The department is distinguished in the diagnosis and treatment of hematologic malignancies, including leukemia, chronic myeloid leukemia (CML), myeloma, and lymphoma, supported by a high-level standardized diagnostic platform using advanced techniques like multi-parameter flow cytometry, chromosome FISH detection, and real-time quantitative PCR. It has been approved as a National Clinical Research Center for Hematological Diseases (2019) and is recognized as a national clinical key discipline and a national clinical drug research base. The department also extends its services through the Peking University People's Hospital Qingdao Hospital Blood Center, providing Beijing-level medical and nursing care and offering green channels and direct transfer services for patients needing HSCT in Beijing.

Rheumatology Department (风湿科): The Rheumatology Department is a national clinical key discipline, an innovative team under the Ministry of Education, and the Beijing Key Laboratory of Rheumatology, also serving as the Asia-Pacific Rheumatology Center. Ranked 2nd nationally, it is internationally renowned for its expertise in the diagnosis, treatment, and mechanism research of rheumatoid arthritis, systemic lupus erythematosus, and Sjögren's syndrome. The department is at the forefront of applying novel biologics, immunoadsorption therapy for refractory rheumatic diseases, and long-term DMARD regimens for rheumatoid arthritis.

Thoracic Surgery Department (胸外科): Ranked 7th nationally, the Thoracic Surgery Department is a national clinical key specialty renowned for its minimally invasive thoracic surgery and the comprehensive treatment of lung cancer, integrating medical care, education, and research. The department is led by Academician Wang Jun, a pioneer in thoracoscopic surgery in China, who developed the "Wang's Technique" which has significantly advanced the adoption of minimally invasive lung cancer surgery in the country. His work also contributed to a National Science and Technology Progress Award in 2012 for the establishment, clinical basic research, and application of a minimally invasive integrated diagnosis and treatment system for lung cancer.

Obstetrics and Gynecology Department (妇产科): Founded in April 1942 by the renowned obstetrician and gynecologist Professor Lin Qiaozhi, the Obstetrics and Gynecology Department is ranked 8th nationally. It offers extensive experience in perinatal care, management of pregnancy complications, and the treatment of complex and critical conditions, with notable progress in prenatal diagnosis. The department focuses on gynecologic oncology, cervical lesions, pelvic floor disorders, gynecologic endocrinology, minimally invasive surgery, and ultrasound diagnostics. It handles over 150,000 outpatient visits and more than 5,000 inpatient admissions annually, with a significant portion of patients traveling from outside Beijing. Dedicated Gynecologic Oncology and Pelvic Floor Disease Treatment Centers have been established. As one of the first units in China to grant master's and doctoral degrees in obstetrics and gynecology, it has trained numerous clinical, research, and teaching talents globally. The hospital provides a NICU (Neonatal Intensive Care Unit) on-site and supports natural birthing alternatives, including analgesia and doula services. VBAC (Vaginal Birth After Cesarean) is supported based on the expectant mother's condition and doctor's opinion. The department also offers fertility treatment options, including Artificial Insemination and In-Vitro Fertilization (IVF).

Orthopedics Department (骨科): Established in 1944 by Professor Feng Chuanhan, a prominent orthopedic surgeon and founder of the Chinese Orthopaedic Association, the Orthopedics Department is the first chair unit of the association and was approved as a national clinical key specialty in 2010. Ranked 9th nationally, it covers a comprehensive range of orthopedic sub-specialties, including trauma, oncology, spine, and joint surgery. The department is a leader in the treatment of severe trauma, periarticular fractures, and nerve injuries, and its bone tumor center is recognized as the largest of its kind internationally. PKUPH plays a central role in national trauma care, having been approved as the main body for the National Trauma Medical Center in 2019. The hospital pioneered the concept of a "closed-loop regional trauma treatment system with comprehensive hospitals as the core" in 2016 and established its Trauma Treatment Center in 2017, which was further developed in the Xizhimen Campus West Annex Building to create a modern emergency rescue and support space. Significant achievements in orthopedics include national awards for projects such as artificial knee replacement and the standardized resection and functional reconstruction of primary malignant bone tumors.

Ophthalmology Department (眼科): The Ophthalmology Department is a modern clinical and research base, ranked 10th nationally. It specializes in retinal and vitreous surgery, offering comprehensive anterior and posterior segment surgeries. Recognized as one of the leading centers in China for the treatment of retinal diseases, it is equipped with advanced diagnostic and therapeutic technologies. The department performs over 5,000 surgeries annually and maintains a leading position in vitreoretinal surgery domestically. Its notable achievements include the successful performance of macular surgery for severe eye injuries in 2000, which restored a patient's vision to 0.6 and was widely reported by Xinhua News Agency.

Medical Checkup Center (体检中心): While the Medical Checkup Center (体检中心) is listed as one of Peking University People's Hospital's specialized departments and is also referred to as the Health Management Center, specific details about its unique services or extensive descriptions of its offerings are not provided in the given sources. It is understood to provide general health examination services as part of the hospital's comprehensive medical care.